A plan for monitoring the patient and instructions for filing an adverse event report if needed
This not only misleads patients, but also poses significant health risks, as these compounded products have not undergone the rigorous FDA approval process that ensures safety, quality, and effectiveness, according to Novo Nordisk, which is seeking monetary damages, injunctive relief, and corrective advertising to inform consumers that its products are not equivalent to FDA-approved semaglutide medications
Medications like Semaglutide and Tirzepatide focus on promoting fat loss, but without the proper strategy, some muscle loss can occur
Research interest centers on its role in maintaining cellular biochemical stability
Diarrhea can occur with Rapivab and Xofluza